| 标题 |
Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medical Economics 作者:Weiting Liao; Jiaxing Huang; David Hutton; Qiu Li 出版日期:2019-01-16 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)